Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
19.14
+0.17 (0.90%)
At close: Mar 9, 2026, 4:00 PM EDT
19.48
+0.34 (1.78%)
After-hours: Mar 9, 2026, 7:57 PM EDT

Legend Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
3,5355,96910,9388,3577,1753,735
Upgrade
Market Cap Growth
-51.46%-45.43%30.89%16.46%92.11%-
Upgrade
Enterprise Value
2,9535,1049,8357,6956,6133,163
Upgrade
Last Close Price
19.1432.5460.1749.9246.6128.16
Upgrade
PS Ratio
3.899.5238.3671.42104.2649.80
Upgrade
PB Ratio
3.505.748.7411.239.376.25
Upgrade
P/TBV Ratio
3.505.758.7711.289.436.28
Upgrade
EV/Sales Ratio
3.258.1434.4965.7696.0842.17
Upgrade
Debt / Equity Ratio
0.410.340.260.380.160.01
Upgrade
Net Debt / Equity Ratio
-0.58-0.74-0.78-1.00-0.99-0.84
Upgrade
Net Debt / EBITDA Ratio
3.212.622.271.661.972.25
Upgrade
Net Debt / FCF Ratio
3.094.882.373.343.162.01
Upgrade
Asset Turnover
0.530.360.180.100.080.15
Upgrade
Inventory Turnover
29.4529.9135.3566.27176.58157.02
Upgrade
Quick Ratio
2.764.496.773.594.115.09
Upgrade
Current Ratio
2.874.626.923.694.145.14
Upgrade
Return on Equity (ROE)
-22.54%-15.45%-51.94%-59.11%-59.19%-71.12%
Upgrade
Return on Assets (ROA)
-6.92%-10.84%-17.39%-23.37%-26.75%-28.32%
Upgrade
Return on Invested Capital (ROIC)
-43.14%-113.06%-322.17%-9433.71%-770.35%-487.69%
Upgrade
Return on Capital Employed (ROCE)
-14.90%-21.90%-27.10%-44.30%-44.30%-37.90%
Upgrade
Earnings Yield
-6.78%-2.97%-4.74%-5.34%-5.62%-7.13%
Upgrade
FCF Yield
-5.34%-2.65%-3.78%-2.66%-3.35%-6.67%
Upgrade
Buyback Yield / Dilution
-0.86%-3.84%-10.71%-12.91%-19.21%-18.15%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.